Individualizing salvage regimens: the inhibitory quotient (Ctrough/IC50) as predictor of virological response

AIDS. 2003 Jan 24;17(2):262-4. doi: 10.1097/01.aids.0000050800.28043.4d.

Abstract

Increased drug levels could overcome resistance and improve the response to a salvage regimen. We evaluate the inhibitory quotient (IQ, Ctrough/protein-binding corrected IC50) as a predictor of virological response in 52 patients included in two dual protease inhibitor (PI)-based salvage regimens. The HIV-RNA level decrease at 12 weeks was greater in patients who achieved an IQ greater than 1. The IQ could be useful to improve the virological response to a dual PI salvage regimen.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Resistance, Viral
  • Drug Therapy, Combination
  • HIV Infections / blood*
  • HIV Infections / drug therapy
  • HIV Protease Inhibitors / blood*
  • HIV Protease Inhibitors / therapeutic use
  • HIV-1 / drug effects*
  • Humans
  • Salvage Therapy

Substances

  • HIV Protease Inhibitors